Skip to main content
. 2022 Jun 27;13:890029. doi: 10.3389/fendo.2022.890029

Figure 3.

Figure 3

Prevalence of coronary heart disease (CHD) and stroke by quartiles of serum dehydroepiandrosterone (DHEA) and dehydroepiandrosterone sulfate (DHEAS) in men and women. (A, B) Prevalence of CHD by DHEA (A) and by DHEAS (B). (C, D) Prevalence of stroke by DHEA (C) and by DHEAS (D). The figure shows that the percentages of men with CHD significantly decreased in accordance with increasing quartiles of serum DHEA and DHEAS (all p < 0.001). The prevalence of stroke significantly decreased in line with increasing quartiles of serum DHEA in women (p = 0.003) and DHEAS in men (p = 0.011).